9975 Summers Ridge Road
San Diego, CA 92121
United States
858 552 1100
https://www.quidelortho.com
Setor(es): Healthcare
Indústria: Medical Devices
Funcionários Integrais: 7.100
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Mr. Michael S. Iskra | Interim CEO, Executive VP & Chief Commercial Officer | 870,93k | N/A | 1970 |
Mr. Robert J. Bujarski J.D. | Interim President, Executive VP & COO | 961,26k | N/A | 1969 |
Mr. Joseph M. Busky CPA | Chief Financial Officer | 890,63k | N/A | 1968 |
Dr. Werner Kroll Ph.D. | Senior Vice President of Research & Development | 1,03M | N/A | 1957 |
Ms. Louise M. Brandy | Chief Information Officer | N/A | N/A | 1959 |
Ruben Argueta | Director of Investor Relations | N/A | N/A | N/A |
Ms. Michelle A. Hodges J.D. | Senior VP, General Counsel & Corporate Secretary | 1,8M | N/A | 1963 |
Mr. William J. Ferenczy | Point of Care Business Unit Leader | N/A | N/A | 1956 |
Ms. Tamara A. Ranalli | Molecular Diagnostics Business Unit Leader | N/A | N/A | 1973 |
O QualityScore de governança da ISS da QuidelOrtho Corporation a partir de 1 de abril de 2024 é 3. As principais pontuações para Auditoria são: 6; Conselho: 2; Direitos de Acionistas: 4; Compensação: 4.